Other
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Amgen Cash Provided by (Used in) Investing Activity, Including Discontinued Operation decreased by 3.3% to -$716.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 60.2%, from -$447.00M to -$716.00M. Over 2 years (FY 2022 to FY 2025), Cash Provided by (Used in) Investing Activity, Including Discontinued Operation shows an upward trend with a -43.3% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Reflects the overall net movement of cash into or out of the investment portfolio and capital assets.
Detailed definition
The total net cash flow from investing activities, aggregating both continuing and discontinued operations. It provides...
Peer comparison
Standard consolidated cash flow metric across all industries.
Metric ID:
other_net_cash_provided_by_used_in_investing_activitiesHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.21B | $73.00M | -$111.00M | -$2.19B | -$267.00M | -$3.47B | $1.36B | -$27.09B | -$217.00M | -$217.00M | -$210.00M | -$402.00M | -$447.00M | -$389.00M | -$414.00M | -$693.00M | -$716.00M |
| QoQ Change | — | -94.0% | -252.1% | <-999% | +87.8% | <-999% | +139.1% | <-999% | +99.2% | +0.0% | +3.2% | -91.4% | -11.2% | +13.0% | -6.4% | -67.4% | -3.3% |
| YoY Change | — | — | — | -281.4% | -465.8% | — | >999% | -680.0% | -116.0% | — | — | +98.5% | -106.0% | -79.3% | -97.1% | -72.4% | -60.2% |
Range-$27.09B – $1.36B
CAGR-12.3%
Avg YoY Growth-48.7%
Median YoY Growth-97.1%
Current Streak3 quarters decline
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Amgen's cash provided by (used in) investing activity, including discontinued operation?
- Amgen (AMGN) reported cash provided by (used in) investing activity, including discontinued operation of -$716.00M in Q1 2026.
- How has Amgen's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Amgen's cash provided by (used in) investing activity, including discontinued operation decreased by 60.2% year-over-year, from -$447.00M to -$716.00M.
- What is the long-term trend for Amgen's cash provided by (used in) investing activity, including discontinued operation?
- Over 2 years (2022 to 2025), Amgen's cash provided by (used in) investing activity, including discontinued operation has grown at a -43.3% compound annual growth rate (CAGR), from -$6.04B to -$1.94B.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow from all investing activities, including both ongoing and discontinued operations.